Merck & Company Inc - Change Receivables
Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.The Serie's long term average value is -1.11 Billion United States Dollars. It's latest available value, on 12/31/2024, is -0.0345 Billion United States Dollars lower, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 12/31/2021, to it's latest available value, on 12/31/2024, is +6.98 Billion.
The Serie's change in United States Dollars from it's maximum value, on 12/31/2019, to it's latest available value, on 12/31/2024, is -2.32 Billion.
Change Receivables for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Eli Lilly and Company - Change Receivables | 905,699,262,464.00 |
 | Johnson & Johnson - Change Receivables | 486,508,953,600.00 |
 | AbbVie Inc - Change Receivables | 399,570,305,024.00 |
 | Roche Holding AG - Change Receivables | 317,433,206,677.55 |
 | AstraZeneca PLC - Change Receivables | 280,205,508,085.11 |